B+
Bull case
25%
Probability
Target price
$190.00
+222.0% vs current
WGS
GeneDxBNasdaq / Health Care Equipment & Services
Last Price
At close
2026-06-18
AI scenario view
RankAlpha Sentiment AIMost likely
B
Base case
60%
Probability
Target price
$155.00
+162.7% vs current
B-
Bear case
15%
Probability
Target price
$120.00
+103.4% vs current
AI sentiment snapshot
Latest data as of 2026-01-16
Recent news sentiment (30D)
-30.2
Negative
Company
-
Unavailable
Macro
-30.2
Negative
Pulse
-
Unavailable
Sentiment proxy
+100.0
Score
AI commentary
Analyst and market sentiment skews constructive with a median target near 155 and several high-end estimates; the wide low/high spread signals model sensitivity to reimbursement and growth timing [#SERP-1] [#SERP-8]. Short-term tone is event-driven around upcoming results and guidance.
RankAlpha Sentiment AI - 2026-01-16
Open full AI memoEvidence flagged
No evidence quality warning is currently attached to this memo.
Impact
standard
Confidence
-
AI events
2026-04-16catalystQuarterly earnings and guidanceHigh impact
Quarterly results and management guidance on test volumes and reimbursement are likely to re-rate the stock; consensus remains dispersed across sell‑side models [#SERP-1].
2026-06-30eventSell‑side target convergenceHigh impact
Consolidation of analyst targets around earnings or consensus refreshes could trigger re-rating events; current high/low spread noted across sources [#SERP-1].
2027-01-16catalystCommercial expansion & payer winsHigh impact
Broader adoption of panels and favorable payer decisions would materially increase revenue visibility and support multiple expansion over the next 12–18 months.
Recommendation
N/A
No formal recommendation provided.
As of 2026-01-16 • Updated nightlySource: Internal modelMethodology